Also trades as: 0HB0.L (LSE) · $vol 0M
AGIO NASDAQ
Agios Pharmaceuticals, Inc.
1W: -2.4%
1M: -6.8%
3M: -14.9%
YTD: +17.0%
1Y: -20.6%
3Y: +29.6%
5Y: -33.1%
$31.80
-0.68 (-2.09%)
Weekly Expected Move ±4.6%
$29
$30
$32
$33
$35
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$98M
Revenue
+140.6% YoY
$-411M
Net Income
-163.3% YoY
$-365M
Free Cash Flow
+10.7% YoY
93.3%
Gross Margin
-247.1%
Op. Margin
-225.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-34.3%
ROA-31.9%
ROIC-82.5%
Valuation
P/E-4.5
P/B1.8
EV/EBITDA-3.9
Leverage
Debt/Equity0.03
Current Ratio10.22
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z14.65
Beneish M-0.25